首页 > 市场调查报告书 > 食物/饮料

食品添加剂

市场调查报告书

商品编码

1455760

全球异黄酮补充剂市场 - 2023-2030

Global Isoflavone Supplements Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球异黄酮补充剂市场规模达到7.212亿美元，预计2030年将达到107.36万美元，2023-2030年预测期间CAGR为5.1%。

随着人们越来越重视天然和植物性产品，消费者正在寻找合成补充剂的替代品。异黄酮是大豆和其他豆类中天然存在的化合物，符合这一趋势，导致对异黄酮补充剂的需求增加。消费者越来越意识到异黄酮的潜在健康益处，特别是在控制更年期症状、促进心臟健康以及潜在降低某些癌症的风险方面。

2021年4月，韩国公司Pulmuone推出了一款用于缓解更年期症状的大豆和啤酒花萃取物补充剂。该公司澄清说，从啤酒花萃取物和黑大豆中提取的异黄酮是有益的，因为它们具有与女性荷尔蒙雌激素的化学结构，雌激素的产生在更年期期间下降并导致更年期症状。

大豆异黄酮补充剂由于富含金雀异黄酮和大豆黄酮等天然异黄酮，占据了一半以上的市场。同样，北美在异黄酮补充剂市场占据主导地位，由于消费者认知度高、研究基础设施健全以及对天然健康解决方案日益浓厚的兴趣，占据了最大的市场份额。

动力学

更年期症状的盛行率上升

随着全球人口老化，越来越多的女性进入更年期。根据美国国家医学图书馆预测，到 2030 年，全球将有 12 亿更年期和停经后女性，其中每年新增 4,700 万人。随着越来越多的女性经历更年期，对有助于控制相关症状的产品的需求也越来越大。

异黄酮是大豆和其他豆类中发现的植物源性化合物，可模仿体内雌激素的作用，并与缓解这些症状有关。随着人们越来越认识到异黄酮补充剂在控制更年期症状方面的潜在益处，对此类产品的需求也在增长。此外，随着全球人口老化的加剧，经历更年期的女性人数不断增加，进一步推动了市场的扩张。

人们对健康益处的认识不断增强

异黄酮是天然存在的化合物，主要存在于大豆和其他豆类中。根据国家医学图书馆的数据，Cancellieri 等人发现，根据 Kupperman 更年期指数，服用含有 72 毫克红三叶草和大豆异黄酮的草药补充剂六个月后，潮热症状显着减少。除了缓解更年期症状外，异黄酮还对骨骼健康具有保护作用，特别是对于骨质疏鬆症风险增加的停经后女性。

异黄酮透过调节骨骼代谢和促进骨形成来帮助维持骨密度并降低骨折风险。此外，人们还研究了异黄酮对心血管的潜在益处，包括透过降低低密度脂蛋白胆固醇水平和增加高密度脂蛋白胆固醇水平来改善血脂状况的能力。随着消费者意识到异黄酮补充剂的潜在好处，对这些产品的需求也相应增加。

监管挑战

监管机构可能会对异黄酮补充剂的营销和标籤施加限製或指导方针，特别是在健康声明和安全问题方面。遵守这些法规可能会增加成本并限制製造商推广其产品的能力，可能会阻碍预测期内的市场扩张。

2020年1月，为了遵守膳食补充剂和婴儿配方奶粉的通报规定，波兰首席卫生监察局宣布实施旨在「加强对企业的监管」的通报制度。 2019 年初，波兰开始对食品补充剂中的物质实施最高限量。在那里，当局製定了异黄酮（大豆和其他）、芦荟和 β-丙氨酸製剂的使用指南和限制。

With a growing emphasis on natural and plant-based products, consumers are seeking alternatives to synthetic supplements. Isoflavones, which are naturally occurring compounds found in soybeans and other legumes, fit into this trend, leading to increased demand for isoflavone supplements. Consumers are becoming increasingly aware of the potential health benefits associated with isoflavones, particularly in managing menopausal symptoms, promoting heart health, and potentially reducing the risk of certain cancers.

In April 2021, Pulmuone, a South Korean company, launched a soybean and hop extract supplement for alleviating menopausal symptoms. The company clarified that isoflavones derived from hop extracts and black soybeans were beneficial because they had a chemical structure with the female hormone estrogen, whose production declines during menopause and causes menopausal symptoms.

The soy-based isoflavone supplements account for over half of the market share due to their rich content of naturally occurring isoflavones, such as genistein and daidzein. Similarly, North America dominates the isoflavone supplements market, capturing the largest market share due to a combination of high consumer awareness, robust research infrastructure, and a growing interest in natural health solutions.

Dynamics

Rising Prevalence of Menopausal Symptoms

As the global population ages, there is a growing number of women entering menopause. According to the National Library of Medicine, it is predicted that by 2030, there will be 1.2 billion menopausal and postmenopausal women worldwide, with 47 million of them joining the population annually. With a larger population of women experiencing menopause, there is a greater demand for products that can help manage associated symptoms.

Isoflavones, plant-derived compounds found in soy and other legumes, mimic the effects of estrogen in the body and have been associated with alleviating these symptoms. As awareness of the potential benefits of isoflavone supplements in managing menopausal symptoms grows, so does demand for such products. Additionally, with an increasing aging population worldwide, the number of women experiencing menopause is on the rise, further propelling the market expansion.

Growing Awareness about Health Benefits

Isoflavones are naturally occurring compounds found predominantly in soybeans and other legumes. According to the National Library of Medicine, Cancellieri et found that Based on the Kupperman Menopause Index, hot flashes were dramatically reduced after six months of consuming a herbal supplement comprising 72 mg of isoflavones from red clover and soybeans. Along with menopausal symptom relief, isoflavones have a protective effect on bone health, particularly in postmenopausal women who are at increased risk of osteoporosis.

Isoflavones help maintain bone density and reduce the risk of fractures by modulating bone metabolism and promoting bone formation. Also, isoflavones have been studied for their potential cardiovascular benefits, including their ability to improve lipid profiles by reducing LDL cholesterol levels and increasing HDL cholesterol levels. As consumers become aware of the potential benefits of isoflavone supplements, there is a corresponding increase in demand for these products.

Regulatory Challenges

Regulatory agencies may impose restrictions or guidelines on the marketing and labeling of isoflavone supplements, particularly regarding health claims and safety concerns. Compliance with these regulations can increase costs and limit the ability of manufacturers to promote their products, potentially hindering market expansion in the forecast period.

In January 2020, to comply with notification regulations for dietary supplements and infant formulas, Poland's Chief Sanitary Inspectorate announced to implementation a notification system aimed at "improving supervision" of firms. At the beginning of 2019, Poland started imposing maximum amounts on substances found in food supplements. There, authorities established usage guidelines and limitations for isoflavones (soy and other), aloe vera, and beta-alanine preparations.

Segment Analysis

The global isoflavone supplements market is segmented based on source, application, distribution channel and region.

Abundance of Isoflavones in Soybeans

Soybeans are a rich source of isoflavones, a type of phytoestrogen. For instance, about 3.5 mg of isoflavones are linked to every gram of soy protein found in soybeans and conventional soy foods. As a result, roughly 25 mg of isoflavones are present in one serving of classic soy food, such as 100 g of tofu or 250 mL of soymilk. These compounds are known for potential health benefits, including reducing the risk of certain chronic diseases such as heart disease and osteoporosis and alleviating menopausal symptoms. Due to this natural abundance, soy has become a primary ingredient in many isoflavone supplements.

In October 2023, Pharmalinea introduced an advanced whole-body menopause supplement. According to Maja Oresnik, Science & Research Director, the new supplement contains Soy isoflavones (Qsoy), resveratrol (Qratrol), and vitamin B6, which has been clinically demonstrated to affect phytoestrogen activity, improve cerebral blood flow and vasodilation, enhance insulin sensitivity and cognitive function, slow down the loss of bone mineral density, and lessen chronic pain.

Geographical Penetration

Growing Awareness about Isoflavone Supplements in North America

There is a growing awareness and interest among consumers in North America regarding the health benefits of isoflavones, particularly in managing conditions such as menopausal symptoms and promoting heart health. According to the National Library of Medicine, every year, about 1.3 million women in the US experience menopause. Isoflavone supplements are often utilized to alleviate menopausal symptoms, providing relief to women experiencing discomfort during this transitional phase of life.

Additionally, North America boasts a well-established dietary supplement industry supported by robust distribution channels and widespread availability of various health products, including isoflavone supplements. The accessibility of these supplements through pharmacies, health food stores, online retailers, and other outlets further contributes to the market's dominance in the region.

COVID-19 Impact Analysis

The COVID-19 pandemic led to widespread disruptions in global supply chains, affecting the production and distribution of various goods, including dietary supplements. Restrictions on movement, lockdown measures, and workforce shortages disrupted the supply of raw materials and manufacturing processes for isoflavone supplements. This resulted in delays in production, shortages in supply, and increased costs for manufacturers, impacting the availability of isoflavone supplements in the market.

However, the pandemic prompted a shift in consumer priorities towards health and wellness. With heightened awareness of immune health and overall well-being, there was increased interest in dietary supplements, including those containing isoflavones. Consumers sought products that could potentially support their immune systems and help manage stress and anxiety during uncertain times. This shift in consumer behavior led to a surge in demand for isoflavone supplements, particularly those marketed for their potential health benefits.

Russia-Ukraine War Impact Analysis

The conflict between Russia and Ukraine disrupted global supply chains, affecting the transportation of goods and raw materials. Ukraine is a significant producer of soybeans, a primary source of isoflavones used in supplements. The disruptions in soybean production and export from Ukraine led to shortages or delays in the availability of raw materials for isoflavone supplements, thereby affecting the supply chain and potentially leading to price fluctuations in the market.

By Source

Soy
Chickpea
Red Clover
Others

By Application

Food & Beverage
Cosmetics
Nutraceuticals
Pharmaceuticals
Others

By Distribution Channel

Hypermarkets/Supermarkets
Drug Stores & Pharmacies
E-Commerce
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In October 2023, Nutravita, a supplement company, released a new line to help women through the menopausal phase of life with a choice of supplements that successfully address the most prevalent symptoms in honor of 'Menopause Awareness Month'. It contains soy isoflavones, which are phytoestrogen chemicals and a natural substitute for hormone replacement treatment, in addition to essential minerals that support menopause.
In February 2023, Pro360, the nutraceutical brand of GMN Group of Companies, launched the FemCare+ and HPHF (High Protein High Fibre) product lines. These products are designed to provide both men and women with a variety of advantages to enhance their lifestyles. Among the enriched, natural ingredients used in the FemCare+ collection are Shatavari, Myo-Inositol, Black Cohosh, Evening Primrose, and Soy Isoflavones.
In November 2021, Otsuka Pharmaceutical Co., Ltd., launched tocoelle, a supplement to support women bothered by pre-menstrual fluctuations. It provides four essential elements: calcium, which is frequently deficient in daily diets; equol, which is made from soy isoflavones; and vitamin E (Y-tocopherol and Y-tocotrienol), which is found in soy oil.
In March 2023, Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced the launch of launch of a new version of EQUELLE gelee, an extension of the EQUELLE brand of supplements promoting women's health and beauty. It has 3.2 mg of soy isoflavones (aglycone), 2,500 mg of collagen peptides, and 5 mg of S-equol.

Competitive Landscape

The major global players in the market include NOW Health Group, Inc., Solgar Inc., Swanson, Life Extension, GNC Holdings, LLC, Pure Encapsulations, Bluebonnet Nutrition, Douglas Laboratories, Jabs Biotech Pvt. Ltd., 21ST Century HealthCare, Inc.

Why Purchase the Report?

To visualize the global isoflavone supplements market segmentation based on source, application, distribution channel, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of isoflavone supplements at the market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global isoflavone supplements market report would provide approximately 62 tables, 56 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Source
3.2.Snippet by Application
3.3.Snippet by Distribution Channel
3.4.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Rising Prevalence of Menopausal Symptoms
  - 4.1.1.2.Growing Awareness about Health Benefits
- 4.1.2.Restraints
  - 4.1.2.1.Regulatory Challenges
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Source

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2.Market Attractiveness Index, By Source
7.2.Soy*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Chickpea
7.4.Red Clover
7.5.Others

8.By Application

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.Food & Beverage*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Cosmetics
8.4.Nutraceuticals
8.5.Pharmaceuticals
8.6.Others

9.By Distribution Channel

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2.Market Attractiveness Index, By Distribution Channel
9.2.Hypermarkets/Supermarkets*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Drug Stores & Pharmacies
9.4.E-Commerce
9.5.Others

10.By Region

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2.Market Attractiveness Index, By Region
10.2.North America
- 10.2.1.Introduction
- 10.2.2.Key Region-Specific Dynamics
- 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1.U.S.
  - 10.2.6.2.Canada
  - 10.2.6.3.Mexico
10.3.Europe
- 10.3.1.Introduction
- 10.3.2.Key Region-Specific Dynamics
- 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1.Germany
  - 10.3.6.2.UK
  - 10.3.6.3.France
  - 10.3.6.4.Italy
  - 10.3.6.5.Russia
  - 10.3.6.6.Rest of Europe
10.4.South America
- 10.4.1.Introduction
- 10.4.2.Key Region-Specific Dynamics
- 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1.Brazil
  - 10.4.6.2.Argentina
  - 10.4.6.3.Rest of South America
10.5.Asia-Pacific
- 10.5.1.Introduction
- 10.5.2.Key Region-Specific Dynamics
- 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1.China
  - 10.5.6.2.India
  - 10.5.6.3.Japan
  - 10.5.6.4.Australia
  - 10.5.6.5.Rest of Asia-Pacific
10.6.Middle East and Africa
- 10.6.1.Introduction
- 10.6.2.Key Region-Specific Dynamics
- 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11.Competitive Landscape

11.1.Competitive Scenario
11.2.Market Positioning/Share Analysis
11.3.Mergers and Acquisitions Analysis

12.Company Profiles

12.1.NOW Health Group, Inc.*
- 12.1.1.Company Overview
- 12.1.2.Product Portfolio and Description
- 12.1.3.Financial Overview
- 12.1.4.Key Developments
12.2.Solgar Inc.
12.3.Swanson
12.4.Life Extension
12.5.GNC Holdings, LLC
12.6.Pure Encapsulations
12.7.Bluebonnet Nutrition
12.8.Douglas Laboratories
12.9.Jabs Biotech Pvt. Ltd.
12.10.21ST Century HealthCare, Inc.

LIST NOT EXHAUSTIVE

13.Appendix

13.1.About Us and Services
13.2.Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球异黄酮补充剂市场 - 2023-2030

Global Isoflavone Supplements Market - 2023-2030

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按来源

第 8 章：按应用

第 9 章：按配销通路

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录